Millipore Sigma Vibrant Logo

341599 FGF-10, Human, Recombinant

FGF-10, Human, Recombinant: Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.
View Products on Sigmaaldrich.com
341599
  
Recuperando precio...
No pudo obtenerse el precio
La cantidad mínima tiene que ser múltiplo de
Maximum Quantity is
Al finalizar el pedido Más información
Ahorró ()
 
—
Solicitar precio
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

       

      Póngase en contacto con el Servicio de Atención al Cliente

      Descripción

      Replacement Information

      Tabla espec. clave

      Purity
      ≥97% by SDS-PAGE
      Description
      OverviewRecombinant, human fibroblast growth factor 10 (FGF-10) consisting of amino acids 137-208 and expressed in E. Coli. Mature human FGF-10, a ~20 kDa protein, contains a serine-rich region near its N-terminus sharing 93% amino acid sequence identity with mouse FGF-10 and 96% with rat FGF-10.
      Catalogue Number341599
      Brand Family Calbiochem®
      References
      ReferencesBeenken, A. and M. Mohammadi. 2009. Nat. Rev. Drug Discov. 8, 235.
      Nomura, S., et al. 2008. Br. J. Cancer 99, 305.
      Zhang, X., et al. 2006. J. Biol. Chem. 281, 15694.
      Beer, H.D., et al. 2005. Oncogene 24, 5269.
      Jaskoll, T., et al. 2005. BMC Dev. Biol. 5, 11.
      Rice, R., et al. 2004. J. Clin. Invest. 113, 1692.
      Donjacour, A.A., et al. 2003. Dev. Biol. 261, 39.
      Mailleux, A.A., et al. 2002. Development 129, 53.
      Sakaue, H., et al. 2002. Genes Dev. 16, 908.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Pirvola, U., et al. 2000. J. Neurosci. 20, 6125.
      Weaver, M., et al. 2000. Development 127, 2695.
      Igarashi, M., et al. 1998. J. Biol. Chem. 273, 13230.
      Min, H., et al. 1998. Genes Dev. 12, 3156.
      Bellusci, S., et al. 1997. Development 124, 4867.
      Emoto, H., et al. 1997. J. Biol. Chem. 272, 23191.
      Product Information
      FormLiquid
      FormulationLyophilized from 0.2 µm sterile-filtered MOPS, Na₂SO₄, EDTA, DTT, BSA.
      Quality LevelMQ100
      Applications
      Biological Information
      Biological activityED₅₀ = 20-100 ng/ml measured in a cell proliferation assay using 4MBr-5 monkey epithelial cells.
      Purity≥97% by SDS-PAGE
      Physicochemical Information
      ContaminantsEndotoxin: <1.0 EU/µg protein
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      341599 0

      Documentation

      FGF-10, Human, Recombinant Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      FGF-10, Human, Recombinant Certificados de análisis

      CargoNúmero de lote
      341599

      Referencias bibliográficas

      Visión general referencias
      Beenken, A. and M. Mohammadi. 2009. Nat. Rev. Drug Discov. 8, 235.
      Nomura, S., et al. 2008. Br. J. Cancer 99, 305.
      Zhang, X., et al. 2006. J. Biol. Chem. 281, 15694.
      Beer, H.D., et al. 2005. Oncogene 24, 5269.
      Jaskoll, T., et al. 2005. BMC Dev. Biol. 5, 11.
      Rice, R., et al. 2004. J. Clin. Invest. 113, 1692.
      Donjacour, A.A., et al. 2003. Dev. Biol. 261, 39.
      Mailleux, A.A., et al. 2002. Development 129, 53.
      Sakaue, H., et al. 2002. Genes Dev. 16, 908.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Pirvola, U., et al. 2000. J. Neurosci. 20, 6125.
      Weaver, M., et al. 2000. Development 127, 2695.
      Igarashi, M., et al. 1998. J. Biol. Chem. 273, 13230.
      Min, H., et al. 1998. Genes Dev. 12, 3156.
      Bellusci, S., et al. 1997. Development 124, 4867.
      Emoto, H., et al. 1997. J. Biol. Chem. 272, 23191.
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision20-Sepmtember-2011 RFH
      DescriptionRecombinant, human fibroblast growth factor 10 (FGF-10) consisting of amino acids 137-208 and expressed in E. Coli. Mature human FGF-10, a ~20 kDa protein, contains a serine-rich region near its N-terminus sharing 93% amino acid sequence identity with mouse FGF-10 and 96% with rat FGF-10.
      FormLiquid
      FormulationLyophilized from 0.2 µm sterile-filtered MOPS, Na₂SO₄, EDTA, DTT, BSA.
      Purity≥97% by SDS-PAGE
      ContaminantsEndotoxin: <1.0 EU/µg protein
      Biological activityED₅₀ = 20-100 ng/ml measured in a cell proliferation assay using 4MBr-5 monkey epithelial cells.
      SolubilityReconstitute to 100 µg/ml in sterile PBS containing at least 0.1% human or bovine serum albumin.
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesBeenken, A. and M. Mohammadi. 2009. Nat. Rev. Drug Discov. 8, 235.
      Nomura, S., et al. 2008. Br. J. Cancer 99, 305.
      Zhang, X., et al. 2006. J. Biol. Chem. 281, 15694.
      Beer, H.D., et al. 2005. Oncogene 24, 5269.
      Jaskoll, T., et al. 2005. BMC Dev. Biol. 5, 11.
      Rice, R., et al. 2004. J. Clin. Invest. 113, 1692.
      Donjacour, A.A., et al. 2003. Dev. Biol. 261, 39.
      Mailleux, A.A., et al. 2002. Development 129, 53.
      Sakaue, H., et al. 2002. Genes Dev. 16, 908.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Pirvola, U., et al. 2000. J. Neurosci. 20, 6125.
      Weaver, M., et al. 2000. Development 127, 2695.
      Igarashi, M., et al. 1998. J. Biol. Chem. 273, 13230.
      Min, H., et al. 1998. Genes Dev. 12, 3156.
      Bellusci, S., et al. 1997. Development 124, 4867.
      Emoto, H., et al. 1997. J. Biol. Chem. 272, 23191.